homocysteine and drospirenone

homocysteine has been researched along with drospirenone in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beretta, L; Caronni, M; Scorza, R1
Battaglia, C; Busacchi, P; Cianciosi, A; Facchinetti, F; Mancini, F; Persico, N1
Bart, S; Diefenbach, K; Marr, J; Sampson-Landers, C; Trummer, D1
Bodur, S; Dundar, O; Kanat-Pektas, M; Kinci, MF; Tutuncu, L1

Trials

2 trial(s) available for homocysteine and drospirenone

ArticleYear
Folate status and homocysteine levels during a 24-week oral administration of a folate-containing oral contraceptive: a randomized, double-blind, active-controlled, parallel-group, US-based multicenter study.
    Contraception, 2012, Volume: 85, Issue:1

    Topics: Adolescent; Adult; Androstenes; Calcium; Contraceptives, Oral; Double-Blind Method; Estrogens; Ethinyl Estradiol; Female; Folic Acid; Glutamates; Homocysteine; Humans; Mineralocorticoid Receptor Antagonists; Neural Tube Defects; Treatment Outcome; Young Adult

2012
The effects of different therapeutic modalities on cardiovascular risk factors in women with polycystıc ovary syndrome: A randomızed controlled study.
    Taiwanese journal of obstetrics & gynecology, 2018, Volume: 57, Issue:3

    Topics: Adult; Androstenes; Apolipoproteins B; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Drug Therapy, Combination; Ethinyl Estradiol; Female; Homocysteine; Humans; Hypoglycemic Agents; Insulin Resistance; Metabolic Syndrome; Metformin; Mineralocorticoid Receptor Antagonists; Peptide Fragments; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Reproductive Control Agents; Risk Factors; Young Adult

2018

Other Studies

2 other study(ies) available for homocysteine and drospirenone

ArticleYear
Systemic sclerosis following oral contraception.
    Clinical rheumatology, 2005, Volume: 24, Issue:3

    Topics: Adult; Androstenes; Antibodies, Antinuclear; Biomarkers; Centromere; Diagnosis, Differential; Female; Follow-Up Studies; Homocysteine; Humans; Menstruation Disturbances; Microscopic Angioscopy; Mineralocorticoid Receptor Antagonists; Progesterone Congeners; Scleroderma, Systemic

2005
Drospirenone and cardiovascular risk in lean and obese polycystic ovary syndrome patients: a pilot study.
    American journal of obstetrics and gynecology, 2010, Volume: 202, Issue:2

    Topics: Adolescent; Adult; Androstenes; Brachial Artery; Cardiovascular Diseases; Contraceptives, Oral; Endothelin-1; Female; Homocysteine; Humans; Insulin; Insulin Resistance; Leptin; Mineralocorticoid Receptor Antagonists; Obesity; Pilot Projects; Polycystic Ovary Syndrome

2010